González-Niño MR, Salmerón-Alcantara AI, Fernández-Ortega MÁ

Language: Spanish
References: 110
Page: 176-184
PDF size: 334.09 Kb.

ABSTRACT

Several studies have reported covid-19-related sequelae affecting sexual and reproductive health in both men and women. In the male population, the most notable consequences include persistent hypogonadism, erectile dysfunction, and alterations in semen parameters, such as reduced ejaculate volume, sperm concentration and motility, as well as increased sperm dna fragmentation, which may negatively affect fertility and quality of life. In women, menstrual irregularities, sexual dysfunction, decreased libido, and transient alterations in ovarian and endometrial function have been described, particularly among those who experienced moderate to severe disease. From a clinical perspective, these sequelae may persist for months or even years after the acute phase of covid-19. However, these infection-related alterations remain poorly recognized and insufficiently understood.

REFERENCES

1. Damiani G, Bragazzi NL, Karimkhani Aksut C, WuD, Alicandro G, McGonagle D, et al. The Global, Regional,and National Burden of Psoriasis: Results andInsights From the Global Burden of Disease 2019 Study.Front Med (Lausanne). 2021;8:743180.

2. Raharja A, Mahil SK, Barker JN. Psoriasis: una brevedescripción general. Clin Med. 2021;21(3):170–173.

3. Rivera-Diaz R, Epelde F, Heras-Hitos JA, MartínezVirto AM, Dávalos Marin AJ, Senán Sanz MR, et al.Generalized pustular psoriasis: practical recommendationsfor Spanish primary care and emergency physicians.Postgrad Med. 2023;135(8):766–74.

4. Kodali N, Blanchard I, Kunamneni S, Lebwohl MG.Current management of generalized pustular psoriasis.Exp Dermatol. 2023;32(8):1204–1218.

5. Daudén E, Vidal D, Romero A, Bordel MT, Rivera R,Márquez J, et al. Gravedad de la psoriasis, calidad devida relacionada con la salud, productividad laboral ydeterioro de la actividad en pacientes con psoriasis moderadaa grave que reciben tratamiento sistémico: datosde la vida real de la práctica clínica en España. ActasDermosifiliogr. 2024;115(1):1–9.

6. Zhang Y, Dong S, Ma Y, Mou Y. Burden of psoriasisin young adults worldwide from the global burdenof disease study 2019. Front Endocrinol (Lausana).2024;15.

7. Rivera-Díaz R, Carrascosa Carrillo JM, Alfonso ZamoraS, Navarro Valdivieso JP, Muñoz Cabello B, RosAbarca S, et al. Improvements in the Management ofPatients With Generalized Pustular Psoriasis in Spain:Recommendations From a Group of Experts. ActasDermosifiliogr. 2024;115(8):801-813.

8. Vilarrasa E, Rivera R, Eiris N, Carretero G, de la CuevaP, Carrascosa JM. Approach to the Epidemiology, DiseaseManagement, and Current Challenges in the Managementof Generalized Pustular Psoriasis Through aSurvey Conducted Among Spanish Dermatologists.Actas Dermosifiliogr. 2024;115(5):449-457.

9. Lupulescu AM, Savu AP, Bucur Ş, Şerban ED, PopescuS, Constantin MM. Hard-to-Treat Areas in Psoriasis:An Underevaluated Part of the Disease. Life (Basel).2025;15(3):425.

10. Fernández-Ávila DG, Charry Anzola LP, González-Cardona LP. Prevalencia de psoriasis en Colombiasegún datos del Registro Nacional en Salud. Actas Dermosifiliogr.2022;113(3):339–341.

11. López-Mejía R, Ramales-Montes EM, Ley-SilvaLS, Romero-Sansalvador CY, Gutiérrez-Gabriel I.Calidad de vida, depresión y su relación con la severidaden la psoriasis. Rev Med Inst Mex Seguro Soc.2022;60(3):315-320.

12. Tsai TS, Ho JC, Chen YJ, Hsiao PF, Lee WR, ChinCC, et al. Health-related quality of life among patientswith moderateto-severe plaque psoriasis in Taiwan. RevMed Dermatologica Sinica. 2018;36:190-195.

13. Von Csiky-Sessoms S, Lebwohl M. What’s New inPsoriasis. Dermatol Clin. 2019;37(2):129-136.

14. Ashonibare VJ, Ashonibare PJ, Akhigbe TM,Akhigbe RE. SARS-CoV-2 impairs male fertilityby targeting semen quality and testosterone level:A systematic review and meta-analysis. PLoS One. 2024;19(9):e0307396.

15. Guo J, Sheng K, Wu S, Chen H, Xu W. An Updateon the Relationship of SARS-CoV-2 andMale Reproduction. Front Endocrinol (Lausanne).2021;12:788321.

16. Cannarella R, Marino M, Crafa A, et al. Impactof COVID-19 on testicular function: asystematic review and meta-analysis. Endocrine.2024;85(1):44-66.

17. Corona G, Vena W, Pizzocaro A, Pallotti F, PaoliD, Rastrelli G, et al. Andrological effects of SARSCov-2 infection: a systematic review and metaanalysis.J Endocrinol Invest. 2022;45(12):2207-19.

18. Markiewicz-Gospodarek A, Wdowiak P, CzeczelewskiM, et al. The Impact of SARS-CoV-2 Infectionon Fertility and Female and Male Reproductive Systems.J Clin Med. 2021;10(19):4520.

19. Sansone A, Mollaioli D, Ciocca G, et al. Addres-sing male sexual and reproductive health in thewake of COVID-19 outbreak. J Endocrinol Invest.2021;44(2):223-31.

20. Li R, Yin T, Fang F, Li Q, Chen J, Wang Y, etal. Potential risks of SARS-CoV-2 infection onreproductive health. Reprod Biomed Online.2020;41(1):89-95.

21. Ata B, Vermeulen N, Mocanu E, et al. SARSCoV-2, fertility and assisted reproduction. Hum ReprodUpdate. 2023;29(2):177-96.

22. Hajizadeh Maleki B, Tartibian B. COVID-19and male reproductive function: a prospective,longitudinal cohort study. Reproduction.2021;161(3):319-31.

23. Erdik A, Gokce AM, Gokce A. The effects of COVID-19 on semen parameter values in healthymales: a single-centre, retrospective study. PeerJ.2025;13:e19864.

24. Yuan L, Sun W, Dong Z, et al. COVID-19 infectionwas associated with poor sperm quality: a cross-sectionaland longitudinal clinical observation study. SciRep. 2025;15(1):11380.

25. Ghazavi B, Nikoozar B, Tavalaee M, Shojaei M, KheirollahiHosseinabadi E, Hayati MJ, et al. TemporalChanges in Sperm Function and Inflammasome ActivityFollowing COVID-19: Evidence for Recovery.COVID. 2025;5(9):152.

26. Pourmasumi S, Nazari A, Ahmadi Z, et al. TheEffect of Long COVID-19 Infection and Vaccinationon Male Fertility; A Narrative Review. Vaccines.2022;10(12):1982.

27. Stigliani S, Massarotti C, Bovis F, Maccarini E, AnseriniP, Scaruffi P. Semen parameters and male reproductivepotential are not adversely affected after threeor more months of recovery from COVID-19 disease.Front Reprod Health. 2023;4:1114308.

28. Yang M, Chen S, Huang B, et al. Pathological Findingsin the Testes of COVID-19 Patients: ClinicalImplications. Eur Urol Focus. 2020;6(5):1124-1129.

29. Giannakopoulos S, Pak J, Bakse J, et al. SARSCoV-2-induced cytokine storm drives prolongedtesticular injury and functional impairment in micethat are mitigated by dexamethasone. PLoS Pathog.2025;21(1):e1012804.

30. Nie X, Qian L, Sun R, et al. Multi-organ proteomiclandscape of COVID-19 autopsies. Cell.2021;184(3):775-791.e14.

31. Rossetti CL, Cazarin J, Hecht F, et al. COVID-19and thyroid function: What do we know so far?Front Endocrinol. 2022;13:1041676.

32. Bornstein SR, Dalan R, Hopkins D, MingroneG, Boehm BO. Endocrine and metabolic linkto coronavirus infection. Nat Rev Endocrinol.

33. 2020;16(6):297-298.20. Panesar A, Gharanei P, Khovanova N, Young L,Grammatopoulos D. Thyroid function duringCOVID-19 and post-COVID complications inadults: a systematic review. Front Endocrinol.2025;15:1477389.

34. El-Naas A, Hamad O, Nair S, Alfakhri B, MahmoudS, Haji A, et al. New onset of type 1 and type 2diabetes post-COVID-19 infection: a systematic review.Emerg Microbes Infect. 2025;14(1):2492211.

35. Chen L, Zhao J, Peng J, et al. Detection of SARSCoV-2 in saliva and characterization of oralsymptoms in COVID-19 patients. Cell Prolif.2020;53(12):e12923.

36. Bhoraniya A, Patel M, Malaviya P, Kushwah M.Assessment of Long-Term Post-COVID Complicationsin Patients with Pre-Existing Metabolic Syndrome:A Prospective Cohort Study. Eur J CardiovascMed. 2025;15:935-8.

37. Bernard I, Limonta D, Mahal LK, Hobman TC.Endothelium Infection and Dysregulation bySARS-CoV-2: Evidence and Caveats in COVID-19.Viruses. 2021;13(1):29.

38. Chen H, Guo H, Zhao Q, et al. Prior COVID-19infection increases degenerated oocytes but does notaffect IVF outcomes: a prospective cohort study.Front Endocrinol. 2025;16:1599771.

39. Sengupta P, Dutta S, Roychoudhury S, D'SouzaUJA, Govindasamy K, Kolesarova A. COVID-19,Oxidative Stress and Male Reproduction: PossibleRole of Antioxidants. Antioxidants. 2022;11(3):548.

40. Falahieh FM, Zarabadipour M, Mirani M, et al.Effects of moderate COVID-19 infection on semenoxidative status and parameters 14 and 120 days afterdiagnosis. Reprod Fertil Dev. 2021;33(12):683-690.

41. Omolaoye TS, Jalaleddine N, Cardona Maya WD,du Plessis SS. Mechanisms of SARS-CoV-2 andMale Infertility: Could Connexin and PannexinPlay a Role? Front Physiol. 2022;13:866675.

42. Jones TH, Kennedy RL. Cytokines and hypothalamic-pituitary function. Cytokine. 1993;5(6):531-538.

43. Bellastella G, Cirillo P, Carbone C, et al. Neuroimmunoendocrinologyof SARS-CoV 2 Infection. Biomedicines.2022;10(11):2855.

44. Sauve F, Nampoothiri S, Clarke SA, et al. Long-COVIDcognitive impairments and reproductive hormonedeficits in men may stem from GnRH neuronaldeath. EBioMedicine. 2023;96:104784.

45. Adamyan L, Elagin V, Vechorko V, et al. A Review ofRecent Studies on the Effects of SARS-CoV-2 Infectionand SARS-CoV-2 Vaccines on Male ReproductiveHealth. Med Sci Monit. 2022;28:e935879.

46. Salonia A, Pontillo M, Capogrosso P, Gregori S, CarenziC, Ferrara AM, et al. Testosterone in males withCOVID-19: A 7-month cohort study. Andrology.2022;10(1):34-41.

47. Salonia A, Pontillo M, Capogrosso P, Pozzi E, FerraraAM, Cotelessa A, et al. Testosterone in males withCOVID-19: a 12-month cohort study. Andrology.2023;11(1):17-23.

48. Amodeo A, Persani L, Bonomi M, Cangiano B. Useof testosterone replacement therapy to treat long-COVID-related hypogonadism. Endocrinol DiabetesMetab Case Rep. 2024;2024(1):23-0097.

49. Kaynar M, Gomes ALQ, Sokolakis I, Gül M. Tip ofthe iceberg: erectile dysfunction and COVID-19. IntJ Impot Res. 2022;34(2):152-157.

50. Bakr AM, El-Sakka AI. Erectile dysfunction amongpatients and health care providers during COVID-19pandemic: A systematic review. Int J Impot Res.2022;34(2):145-151.

51. Zhang J, Shi W, Zou M, et al. Prevalence and riskfactors of erectile dysfunction in COVID-19 patients:a systematic review and meta-analysis. J EndocrinolInvest. 2023;46(4):795-804.

52. Hadibrata E, Sutyarso S, Busman H, Sumardi S.Erectile Dysfunction and Ejaculatory Dysfunctionin Covid-19 Recovered Patient: Temporary or Persistent?Urol J. 2025;22(2):102-105.

53. Kato H, Ichihara N, Saito H, Fujitani S, Ota K,Takahashi Y, et al. Prevalence of erectile dysfunctionas long-COVID symptom in hospitalized Japanesepatients. Sci Rep. 2025;15(1):6279.

54. Harirugsakul K, Wainipitapong S, Phannajit J, PaitoonpongL, Tantiwongse K. Erectile dysfunctionafter COVID-19 recovery: A follow-up study. PLoSOne. 2022;17:e0276429.

55. Paoli D, Pallotti F, Anzuini A, Bianchini S, CaponecchiaL, Carraro A, et al. Male reproductive health after3 months from SARS-CoV-2 infection: a multicentricstudy. J Endocrinol Invest. 2022;46:589-601.

56. Zhang QF, Zhang YJ, Wang S, et al. Does COVID-19affect sperm quality in males? the answer may be yes,but only temporarily. Virol J. 2024;21(1):24.

57. Shcherbitskaia AD, Komarova EM, Milyutina YP,Ishchuk MA, Sagurova YM, Safaryan GK, Lesik EA,Gzgzyan AM, Bespalova ON, Kogan IY. OxidativeStress Markers and Sperm DNA Fragmentation inMen Recovered from COVID-19. Int J Mol Sci.2022;23(17):10060.

58. Asadi Z, Vaisi-Raygani A, Safari-Faramani R, GhasemiM, Aghaz F. Association Between SARS-COV-2Infection and Sperm DNA Fragmentation: A SystematicReview and Meta-Analysis. Am J Reprod Immunol.2025;94(2):e70143.

59. Sengupta P, Dutta S. Does SARS-CoV-2 infectioncause sperm DNA fragmentation? Possible link withoxidative stress. Eur J Contracept Reprod HealthCare. 2020;25(5):405-406.

60. Madab IQ, Hamid NI, Nima MH, Manea H, MadabSQ, Naser IH. COVID-19 pandemic effects on seminalfluid analysis parameters: A prospective cohortstudy. J Med Access. 2025;9:27550834251366837.

61. Beesley MA, Davidson JR, Panariello F, et al. COVID-19 and vertical transmission: assessing the expressionof ACE2/TMPRSS2 in the human fetus andplacenta to assess the risk of SARS-CoV-2 infection.BJOG. 2022;129(2):256-266.

62. Wu M, Ma L, Xue L, et al. Co-expression of theSARS-CoV-2 entry molecules ACE2 and TMPRSS2in human ovaries: Identification of cell types andtrends with age. Genomics. 2021;113(6):3449-3460.

63. Chadchan SB, Popli P, Maurya VK, Kommagani R.The SARS-CoV-2 receptor, angiotensin-converting enzyme2, is required for human endometrial stromal celldecidualization. Biol Reprod. 2021;104(2):336-343.

64. Shook LL, Bordt EA, Meinsohn MC, et al. PlacentalExpression of ACE2 and TMPRSS2 in MaternalSevere Acute Respiratory Syndrome Coronavirus 2Infection: Are Placental Defenses Mediated by FetalSex? J Infect Dis. 2021;224(Suppl 6):S647-S659.

65. Zafari Zangeneh F. Interaction of SARS-CoV-2With RAS/ACE2 in the Female Reproductive System.J Family Reprod Health. 2022;16(1):1-8.

66. Herr D, Bekes I, Wulff C. Local Renin-Angiotensinsystem in the reproductive system. Front Endocrinol(Lausanne). 2013;4:150.

67. Jing Y, Run-Qian L, Hao-Ran W, et al. Potentialinfluence of COVID-19/ACE2 on the femalereproductive system. Mol Hum Reprod.2020;26(6):367-373.

68. D'Ippolito S, Turchiano F, Vitagliano A, et al. IsThere a Role for SARS-CoV-2/COVID-19 onthe Female Reproductive System? Front Physiol.2022;13:845156.

69. Nazari M, Pajokh M. The Evaluation of Post-COVID-19 Effects on Ovarian Reserve and Menstruationin Reproductive-Aged Women in 2022: ASingle-Centered Observational Study. Middle East JRehabil Health Stud. 2024;11(3):e145630.

70. Dong S, Liu X, Wang Y. The impact of COVID-19on women's reproductive system. Front Med (Lausanne).2024;11:1485022.

71. Li J, Zhou Y, Ma J, et al. The long-term healthoutcomes, pathophysiological mechanisms andmultidisciplinary management of long COVID.Signal Transduct Target Ther. 2023;8(1):416.

72. Su R, Lin J, Duan H, Wang W, An J. Effects ofSARS-CoV-2 Infection on Menstruation in VaccinatedWomen: A Monocentric Retrospective Study.CEOG. 2024;51(7):168.

73. Dong J, Ni J, Zhang Z, Yan H, Xu J, Zhao J.The impact of long COVID on menstruation inChinese female college students and the interventionof acupuncture. Medicine (Baltimore).2024;103(6):e36818.

74. Harb J, Debs N, Rima M, et al. SARS-CoV-2,COVID-19, and Reproduction: Effects on Fertility,Pregnancy, and Neonatal Life. Biomedicines.2022;10(8):1775.

75. Phelan N, Behan LA, Owens L. The Impact ofthe COVID-19 Pandemic on Women's ReproductiveHealth. Front Endocrinol (Lausanne).2021;12:642755.

76. Barabás K, Makkai B, Farkas N, et al. Influenceof COVID-19 pandemic and vaccination on themenstrual cycle: A retrospective study in Hungary.Front Endocrinol (Lausanne). 2022;13:974788.

77. Cherenack EM, Salazar AS, Nogueira NF, et al. Infectionwith SARS-CoV-2 is associated with menstrualirregularities among women of reproductiveage. PLoS One. 2022;17(10):e0276131.

78. Hannoun AB, Nassar AH, Usta IM, Zreik TG, AbuMusa AA. Effect of war on the menstrual cycle. ObstetGynecol. 2007;109(4):929-932.

79. Liu S, Han J, Xiao D, et al. Informe sobre la saludreproductiva de las mujeres tras el devastador terremotode Wenchuan de 2008. Int J Gynecol Obstet.2010;108(2):161-164.

80. Maher M, Owens L. SARS-CoV-2 infectionand female reproductive health: A narrative review.Best Pract Res Clin Endocrinol Metab.2023;37(4):101760.

81. Doğan E, Uncu B, Duman R. Comparison ofmenstrual cycle irregularities among young womenbased on coronavirus disease 2019 infectionstatus: a cross-sectional study. Rev Assoc Med Bras.2024;70(2):e20230801.

82. Smaardijk VR, Jajou R, Kant A, van Hunsel FPAM.Menstrual disorders following COVID-19 vaccination:a review using a systematic search. Front DrugSaf Regul. 2024;4:1338466.

83. Reed MA. Female Sexual Dysfunction. Clin PlastSurg. 2022;49(4):495-504.

84. Clayton AH, Valladares Juarez EM. Female SexualDysfunction. Psychiatr Clin North Am.2017;40(2):267-284.

85. Voutskidou A, Kirkou G, Dagla M, et al. COVID-19 Pandemic and Its Impact on the Quality ofWomen's Sexual Life: A Systematic Review. Healthcare(Basel). 2023;11(2):185.

86. Yuksel B, Ozgor F. Effect of the COVID-19 pandemicon female sexual behavior. Int J Gynaecol Obstet.2020;150(1):98-102.

87. Nawaz MU, Rivera E, Vinayak S, et al. Comparisonof Sexual Function Before and After COVID-19 Infection in Female Patients. Cureus.2021;13(9):e18156.

88. Ketenci Gencer F, Yuksel S, Salman S, KumbasarS, Kobaner N. Evaluation of Women's SexualFunctions After COVID-19 Infection. Sisli EtfalHastan Tip Bul. 2022;56(3):328-333.

89. Hessami K, Sayegh N, Abdolmaleki AS, et al.Women's sexual function before and during COVID-19 pandemic: A systematic review and metaanalysis.J Obstet Gynaecol Res. 2022;48(9):2285-2295.

90. Vo TM, Nguyen TT, Nguyen DQ, Hoang TT,Duong U kt, Nguyen VC, et al. Sexual dysfunctionin reproductive-aged women post-SARS-Cov-2 infection:A study in Ho Chi Minh City, Vietnam.Med Sci. 2024;28(148):1-11.

91. Buoite Stella A, Furlanis G, Frezza NA, ValentinottiR, Ajcevic M, Manganotti P. Autonomic dysfunctionin post-COVID patients with and witfhout neurologicalsymptoms: a prospective multidomain observationalstudy. J Neurol. 2022;269(2):587-596.

92. Pollack B, von Saltza E, McCorkell L, et al. Femalereproductive health impacts of Long COVID andassociated illnesses including ME/CFS, POTS, andconnective tissue disorders: a literature review. FrontRehabil Sci. 2023;4:1122673.

93. Qiu L, Liu X, Xiao M, et al. SARS-CoV-2 Is NotDetectable in the Vaginal Fluid of Women WithSevere COVID-19 Infection. Clin Infect Dis.2020;71(15):813-817.

94. Khoiwal K, Kalita D, Shankar R, et al. Identificationof SARS-CoV-2 in the vaginal fluid and cervicalexfoliated cells of women with active COVID-19infection: A pilot study. Int J Gynaecol Obstet.2021;153(3):551-553.

95. Barber E, Kovo M, Leytes S, et al. Evaluation ofSARS-CoV-2 in the Vaginal Secretions of Womenwith COVID-19: A Prospective Study. J Clin Med.2021;10(12):2735.

96. Aslan MM, Uslu Yuvacı H, Köse O, et al. SARSCoV-2 is not present in the vaginal fluid of pregnantwomen with COVID-19. J Matern Fetal NeonatalMed. 2022;35(15):2876-2878.

97. Fenizia C, Saulle I, Di Giminiani M, et al. UnlikelySARS-CoV-2 Transmission During Vaginal Delivery.Reprod Sci. 2021;28(10):2939-2941.

98. Voros C, Varthaliti A, Athanasiou D, et al. MicroRNASignatures in Endometrial Receptivity-Unlocking Their Role in Embryo Implantation andIVF Success: A Systematic Review. Biomedicines.2025;13(5):1189.

99. Guo S, Li Z, Yan L, Sun Y, Feng Y. GnRH agonistimproves pregnancy outcome in mice with inducedadenomyosis by restoring endometrial receptivity.Drug Des Devel Ther. 2018;12:1621-1631.

100. Salmasi S, Heidar MS, Khaksary Mahabady M, RashidiB, Mirzaei H. MicroRNAs, endometrial receptivityand molecular pathways. Reprod Biol Endocrinol.2024;22(1):139.

101. Chamani IJ, Chung MS, Cochran RA, Gibbons WE,McKenzie LJ. ART outcomes during the COVID-19PANDEMIC. Fertil Steril. 2021;116(1):e8-e9.

102. Wang R, Lin Y, Chen L, et al. The impact of COVID-19 infection on ART outcomes: a multicenterretrospective cohort study. J Ovarian Res.2025;18(1):156.

103. Dolgushina NV, Витальевна ДН, Ermakova DM,Михайловна ЕД, Lomova NA, Анатольевна ЛН,et al. The impact of COVID-19 on the outcomes ofassisted reproductive technology programs. Obstetricsand Gynecology. 2022;(10):115-22.

104. Nielsen SY, Hvidman LE, Aabakke AJM, Olsen TE,Johnsen IBG, Bogaard PW, et al. SARS-CoV-2 placentitisand severe pregnancy outcome after maternalinfection: A Danish case series. Acta Obstet GynecolScand. 2023;102(5):567-76.

105. Schwartz DA, Mulkey SB, Roberts DJ. SARS-CoV-2placentitis, stillbirth, and maternal COVID-19 vaccination:clinical-pathologic correlations. Am J ObstetGynecol. 2023;228(3):261-269.

106. Watkins JC, Torous VF, Roberts DJ. Defining SevereAcute Respiratory Syndrome Coronavirus 2(SARS-CoV-2) Placentitis. Arch Pathol Lab Med.2021;145(11):1341-1349.

107. Farran SH, Rabah R, Simon C. SARS-CoV-2 Placentitis:A Review of Pathologic Findings and Discussionof Differential Diagnosis. Arch Pathol Lab Med.2025;149(9):e291-e297.

108. Huynh A, Sehn JK, Goldfarb IT, et al. SARS-CoV-2Placentitis and Intraparenchymal ThrombohematomasAmong COVID-19 Infections in Pregnancy.JAMA Netw Open. 2022;5(3):e225345.

109. Schwartz DA. Stillbirth after COVID-19 in UnvaccinatedMothers Can Result from SARS-CoV-2Placentitis, Placental Insufficiency, and Hypoxic IschemicFetal Demise, Not Direct Fetal Infection: PotentialRole of Maternal Vaccination in Pregnancy.Viruses. 2022;14(3):458.

110. Redline RW, Ravishankar S, Bagby C, Saab S, ZareiS. Diffuse and Localized SARS-CoV-2 Placentitis:Prevalence and Pathogenesis of an Uncommon Complicationof COVID-19 Infection During Pregnancy.Am J Surg Pathol. 2022;46(8):1036-1047.